Efficacy and safety of office-based diode laser ablation for recurrent low-grade non-muscle-invasive bladder cancer under local anaesthesia: A pilot study

References

• Babjuk M, Burger M, Capoun O, et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (ta, T1, and carcinoma in situ). Eur Urol. 2022 Jan;81(1):75–94. doi: 10.1016/j.eururo.2021.08.010 Epub 2021 Sep 10. PMID: 34511303.
   PubMed Web of Science ®Google Scholar
• Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021. doi: 10.1016/j.juro.2016.06.049
   PubMed Web of Science ®Google Scholar
• Im Jk, Moon KC, Jeong CW, et al. Papillary urothelial neoplasm of low malignant potential (PUNLMP) after initial TUR-BT: comparative analyses with noninvasive low-grade papillary urothelial carcinoma (LGPUC). J Cancer. 2017;8(15):2885–2891. doi: 10.7150/jca.20003
   PubMed Web of Science ®Google Scholar
• Matulay JT, Soloway M, Witjes JA, et al. Risk-adapted management of low-grade bladder tumours: recommendations from the international bladder cancer group (IBCG). BJU Int. 2020;125(4):497–505. doi: 10.1111/bju.14995
   PubMed Web of Science ®Google Scholar
• Xu J, Wang C, Ouyang J, et al. Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: a meta-analysis and systematic review. Urol Int. 2020;104(9–10):810–823. doi: 10.1159/000506655
   PubMed Web of Science ®Google Scholar
• Alaali HH, Irwin MG. Anaesthesia for urological surgery. Anaesth & Intensive Care Med. 2021;22(7):449–453. doi: 10.1016/j.mpaic.2021.05.006
   Web of Science ®Google Scholar
• Staheli B, Rondeau B. Anesthetic considerations in the geriatric population. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 34283503.
   Google Scholar
• Sievert Kd, Amend B, Nagele U, et al. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol. 2009;27(3):295–300. doi: 10.1007/s00345-009-0395-z
   PubMed Web of Science ®Google Scholar
• Nair R, Thurairaja R, Russell B, et al. Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: a retrospective cohort study. BJUI Compass. 2022;3(2):124–129. doi: 10.1002/bco2.120GROVERETAL.129
   PubMedGoogle Scholar
• Bai Y, Liu L, Yuan H, et al. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis. World J Surg Onc. 2014;12(1):301. doi: 10.1186/1477-7819-12-301
   PubMedGoogle Scholar
• Wong KA, Zisengwe G, Athanasiou T, et al. Outpatient laser ablation of non-muscle invasive bladder cancer; is it safe, tolerable and cost-effective? BJU Int. doi: 10.1111/bju.12216
   Web of Science ®Google Scholar
• Malde S, Grover S, Raj S, et al. A systematic review of the efficacy and safety of outpatient bladder tumour ablation. Eur Urol Focus. 2022;8(1):141–151, ISSN 2405-4569, doi: 10.1016/j.euf.2021.01.019
   PubMedGoogle Scholar
• Karcioglu O, Topacoglu H, Dikme O, et al. A systematic review of the pain scales in adults: which to use? The American Journal of Emergency Medicine. 2018;36(4):707–714. doi: 10.1016/j.ajem.2018.01.008
   PubMed Web of Science ®Google Scholar
• Gofrit ON, Pode D, Pizov G, et al. ‘Very-low-risk’ bladder tumours – a new entity? BJU Int. 2018;121(4):627–631. doi: 10.1111/bju.14108
   PubMed Web of Science ®Google Scholar
• Aaronson DS, Walsh TJ, Smith JF, et al. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int. 2009;104(4):506–510. doi: 10.1111/j.1464-410X.2009.08417.x
   PubMed Web of Science ®Google Scholar
• Singh A, Kayina CA, Naik N, et al. Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the incidence of catheter related bladder discomfort in transurethral resection of bladder tumors: a randomized, double blind, controlled trial. Int J Urol. 2023 Mar;30(3):264–270. doi: 10.1111/iju.15100 Epub 2022 Nov 14. PMID: 36375083.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–653. doi: 10.1016/j.eururo.2013.06.003
   PubMed Web of Science ®Google Scholar
• Yu J, Zheng J. Comparative efficacy and safety of transurethral laser surgery with holmium laser, KTP laser, 2-micron laser or thulium laser for the treatment of non-muscle invasive bladder carcinoma: a protocol of network meta-analysis. BMJ Open. 2021;11(12):e055840. doi: 10.1136/bmjopen-2021-055840
   PubMed Web of Science ®Google Scholar
• Xu J, Wang C, Ouyang J, et al. Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: a meta-analysis and systematic review. Urol Int. 2020;104(9–10):810–823. doi: 10.1159/000506655 Epub 2020 May 27. PMID: 32460292.
   PubMed Web of Science ®Google Scholar
• D’souza N, Verma A. Holmium laser transurethral resection of bladder tumor: our experience. Urol Ann. 2016 Oct-Dec;8(4):439–443. doi: 10.4103/0974-7796.190815 PMID: 28057988; PMCID: PMC5100149.
   PubMedGoogle Scholar
• Mao T, Zhang H, Cui J, et al. The 980 nm diode laser treatment for non-muscle-invasive bladder tumor with en bloc technique: single-center experience. World J Surg Onc. 2022;20(1):324. 29 Sep. doi: 10.1186/s12957-022-02786-w
   PubMed Web of Science ®Google Scholar
• Fernandez-Gomez J, Solsona E, Unda M, et al. Prognostic factors in patients with non–muscle-Invasive bladder cancer treated with Bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials. Eur Urol. 2008;53(5):992–1002. doi: 10.1016/j.eururo.2007.10.006
   PubMed Web of Science ®Google Scholar
• Sylvester RJ. Natural history, recurrence, and progression in superficial bladder cancer. ScientificWorldjournal. [2006 Mar 27];6:2617–2625. doi: 10.1100/tsw.2006.404 PMID: 17619739; PMCID: PMC5917231.
   PubMedGoogle Scholar
• Simon M, Bosset P-O, Rouanne M, et al. Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score. PLoS One. 2019;14(2):e0211721. doi: 10.1371/journal.pone.0211721
   PubMed Web of Science ®Google Scholar
• Bryan RT, Collins SI, Daykin MC, et al. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surgeons Engl. 2010;92(6):519–524. doi: 10.1308/003588410X12664192076935
   PubMed Web of Science ®Google Scholar
• Jancke G, Rosell J, Jahnson S. Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011 Dec;45(6):388–392. doi: 10.3109/00365599.2011.590995 Epub 2011 Jun 16. PMID: 21679018.
   PubMed Web of Science ®Google Scholar
• Liu Z, Long G, Zhang Y, et al. Thulium laser resection of bladder tumors vs. conventional transurethral resection of bladder tumors for intermediate and high risk non-muscle-invasive bladder cancer followed by intravesical BCG immunotherapy. Front Surg. 2021;8:759487. doi: 10.3389/fsurg.2021.759487
   PubMed Web of Science ®Google Scholar
• Razzaghi MR, Mazloomfard MM, Yavar M, et al. Holmium laser in comparison with transurethral resection of the bladder tumor for non-muscle invasive bladder cancer: randomized clinical trial with 18-month follow-up. Urol J. 2021;18(4):460–465. doi: 10.22037/uj.v18i.6319
   PubMed Web of Science ®Google Scholar
• Gautier Hermann G, Mogensen K, Rosthøj S. Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis. Scand J Urol. 2018. doi: 10.1080/21681805.2018.1450782
   Web of Science ®Google Scholar
• Khalil IA, Aldeeb M, Mohammed A, et al. The role of rezum in the management of refractory urinary retention due to benign prostate hyperplasia: a literature review. Arab J Urol. 2023;21(3):185–189. doi: 10.1080/2090598X.2023.2178104
   PubMed Web of Science ®Google Scholar
• D’Souza N, Verma A. Holmium laser cystolithotripsy under local anaesthesia: our experience. Arab J Urol. [2016 Jul 11];14(3):203–206. doi: 10.1016/j.aju.2016.06.002
   PubMedGoogle Scholar